Adverse Event Reporting

VAERS ID	1593758
Gender	Female
Age
StateCode	FR
Pharmaceutical Company	PFIZER\BIONTECH
Lot Number
Number of vaccinations	1
Vaccinated
Onset
Condition

Symptoms

• Thrombocytopenia

Current Illness

Preexisting Conditions

Medical History/Concurrent Conditions: Dyslipidemia; Obesity (grade III)

Other Medications

Previous Vaccinations

Allergies

Laboratory Data

Write-up

Thrombocytopenia; This is a Spontaneous report from a non-contactable Other Health Professional.
This is a report received from Health Authority via email.
Regulatory authority report number is 17315-8.
A 50-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Not reported) via an unspecified route of administration, administered on an unspecified date as a single dose for covid-19 immunisation.
Medical history included obesity (grade III), dyslipidaemia.
The patient's concomitant medications were not reported.
It was reported that on an unspecified date the patient experienced thrombocytopenia.
Clinical course was a 50-year-old female patient with a diagnosis of grade 3 obesity, dyslipidemia and thrombocytopenia under study, refers immediate symptoms after the vaccination, the case was already known due to presence of adverse event after the first dose, has received treatment with ibuprofen, it is requested to attend an evaluation with family doctor to continue protocol.
The outcome of event was unknown.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No further information is expected.